Autoimmune disease needs a specialist team, not a refill.
Rheumatoid arthritis, lupus, inflammatory bowel disease, and other autoimmune conditions get treated as a prescription to renew instead of a coordinated care plan. Ciba builds the plan, with a physician-led biologics strategy and a specialist team that actually talks to each other.
Complex disease, disconnected care.
AccessSpecialist wait times for rheumatology and gastroenterology push members into unmanaged flares.
CostBiologic therapies are among the most expensive drug classes on any formulary. Utilization management alone doesn’t lower spend.
CoordinationRheumatology, gastroenterology, dermatology, and primary care rarely share one plan for a patient with overlapping autoimmune conditions.
MonitoringFlares get caught at the next scheduled visit, not when they start.
One coordinated plan, led by a physician.
Biologic therapy managed with the same rigor as any other complex medication: right drug, right dose, and a team watching for what changes between visits.
Comprehensive autoimmune workup
Physician-led diagnosis and staging, built to find the specific condition, not just treat the symptom.
Biologic optimization and formulary navigation
Coordinated step therapy, dose management, and formulary strategy for high cost biologic therapies.
One plan across specialties
Rheumatology, gastroenterology, dermatology, and primary care working from a single, shared care plan.
Remote flare and symptom tracking
Continuous monitoring between specialist visits, so a flare gets a response in days, not at the next appointment.
Documented outcomes, not a claim.
Members in the cohort
Symptom improvement
Medication burden reduction
Pharmacy return on investment
For health plan and health system partners: full cohort methodology and outcomes documentation is available for clinical validation and medical policy review. See our Health Plans & Payers page.